Free Trial

Deutsche Bank AG Buys 131,897 Shares of Xylem Inc. (NYSE:XYL)

Xylem logo with Business Services background

Key Points

  • Deutsche Bank AG increased its stake in Xylem Inc. by 6.8% during the first quarter, now owning approximately 0.86% of the company, valued at about $248.88 million.
  • Xylem reported an earnings per share (EPS) of $1.26 for the latest quarter, surpassing analyst estimates and showing a 6.1% revenue growth compared to last year.
  • The company declared a quarterly dividend of $0.40 per share, resulting in an annualized yield of 1.1% and a payout ratio of 41.56%.
  • Need Better Tools to Track Xylem? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Deutsche Bank AG raised its stake in shares of Xylem Inc. (NYSE:XYL - Free Report) by 6.8% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,083,412 shares of the industrial products company's stock after acquiring an additional 131,897 shares during the period. Deutsche Bank AG owned about 0.86% of Xylem worth $248,884,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Dynamic Advisor Solutions LLC purchased a new stake in shares of Xylem during the 1st quarter valued at $694,000. Farther Finance Advisors LLC increased its position in shares of Xylem by 30.4% during the 1st quarter. Farther Finance Advisors LLC now owns 1,797 shares of the industrial products company's stock valued at $215,000 after purchasing an additional 419 shares during the last quarter. NBC Securities Inc. purchased a new stake in shares of Xylem during the 1st quarter valued at $72,000. GAMMA Investing LLC increased its position in shares of Xylem by 29.1% during the 1st quarter. GAMMA Investing LLC now owns 4,241 shares of the industrial products company's stock valued at $507,000 after purchasing an additional 956 shares during the last quarter. Finally, Cambridge Investment Research Advisors Inc. increased its position in shares of Xylem by 19.4% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 27,215 shares of the industrial products company's stock valued at $3,251,000 after purchasing an additional 4,429 shares during the last quarter. 87.96% of the stock is currently owned by institutional investors.

Xylem Price Performance

NYSE:XYL traded down $0.78 during mid-day trading on Friday, reaching $142.71. The stock had a trading volume of 596,988 shares, compared to its average volume of 1,140,855. The firm has a 50 day moving average price of $131.23 and a two-hundred day moving average price of $125.14. The stock has a market capitalization of $34.74 billion, a P/E ratio of 37.07, a P/E/G ratio of 2.48 and a beta of 1.11. Xylem Inc. has a one year low of $100.47 and a one year high of $145.33. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.43 and a current ratio of 1.90.

Xylem (NYSE:XYL - Get Free Report) last released its earnings results on Thursday, July 31st. The industrial products company reported $1.26 earnings per share for the quarter, topping analysts' consensus estimates of $1.15 by $0.11. The company had revenue of $2.30 billion during the quarter, compared to the consensus estimate of $2.20 billion. Xylem had a return on equity of 10.33% and a net margin of 10.74%. Xylem's quarterly revenue was up 6.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.09 EPS. As a group, analysts expect that Xylem Inc. will post 4.65 earnings per share for the current year.

Xylem Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 26th. Shareholders of record on Thursday, May 29th were given a $0.40 dividend. The ex-dividend date was Thursday, May 29th. This represents a $1.60 annualized dividend and a yield of 1.1%. Xylem's payout ratio is presently 41.56%.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on XYL shares. JPMorgan Chase & Co. started coverage on Xylem in a report on Friday, May 30th. They issued an "overweight" rating and a $148.00 price objective for the company. UBS Group lifted their price objective on Xylem from $164.00 to $168.00 and gave the stock a "buy" rating in a report on Tuesday. Stifel Nicolaus lifted their price objective on Xylem from $162.00 to $175.00 and gave the stock a "buy" rating in a report on Friday, August 1st. Robert W. Baird decreased their price objective on Xylem from $149.00 to $146.00 and set an "outperform" rating for the company in a report on Wednesday, April 30th. Finally, Wall Street Zen raised Xylem from a "hold" rating to a "buy" rating in a report on Saturday. Three research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat.com, Xylem presently has an average rating of "Moderate Buy" and a consensus target price of $151.57.

Read Our Latest Stock Analysis on Xylem

About Xylem

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Featured Articles

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Should You Invest $1,000 in Xylem Right Now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines